{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:56:28Z","timestamp":1791507388271,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T00:00:00Z","timestamp":1480636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T00:00:00Z","timestamp":1480636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hepatoblastoma (HBL), the most common childhood liver cancer is cured with surgical resection after chemotherapy or with liver transplantation if local invasion and multifocality preclude resection. However, variable survival rates of 60\u201380% and debilitating chemotherapy sequelae argue for more informed treatment selection, which is not possible by grading the Wnt-\u03b2-catenin over activity present in most HBL tumors. A hypothesis-generating whole transcriptome analysis shows that HBL tumors removed at transplantation are enriched most for cancer signaling pathways which depend predominantly on epidermal growth factor (EGF) signaling, and to a lesser extent, on aberrant Wnt-\u03b2-catenin signaling. We therefore evaluated whether EGFR, ASAP1, ERBB2 and ERBB4, which signal downstream after ligation of EGF, and which show aberrant expression in several other invasive cancers, would also predict HBL tumor invasiveness. Immunohistochemistry of HBL tumors (n\u2009=\u200960), which are histologically heterogeneous, shows that compared with well-differentiated fetal cells, less differentiated embryonal and undifferentiated small cells (SCU) progressively lose EGFR and ASAP1 expression. This trend is exaggerated in unresectable, locally invasive or metastatic tumors, in which embryonal tumor cells are EGFR-negative, while SCU cells are EGFR-negative and ASAP1-negative. Loss of EGFR-ASAP1 signaling characterizes undifferentiated and invasive HBL. EGFR-expressing HBL tumors present novel therapeutic targeting opportunities.<\/jats:p>","DOI":"10.1038\/srep38347","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T05:40:25Z","timestamp":1480657225000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Loss of EGFR-ASAP1 signaling in metastatic and unresectable hepatoblastoma"],"prefix":"10.1038","volume":"6","author":[{"given":"Sarangarajan","family":"Ranganathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mylarappa","family":"Ningappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chethan","family":"Ashokkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon W.","family":"Higgs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakon","family":"Hakonarson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Sindhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,2]]},"reference":[{"key":"BFsrep38347_CR1","unstructured":"Bulterys, M. et al. Hepatic tumors. In: Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975\u20131995 (eds. Ries, L., Smith, M. & Gurney, J. ). Bethesda: National Cancer Institute; 91\u201397 (1999)."},{"key":"BFsrep38347_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.surg.2012.11.006","volume":"153","author":"RJ Cruz","year":"2013","unstructured":"Cruz, R. J. et al. Analysis of national and single-center incidence and survival after liver transplantation for hepatoblastoma: new trends and future opportunities. Surgery 153, 150\u2013159 (2013).","journal-title":"Surgery"},{"key":"BFsrep38347_CR3","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/modpathol.2013.80. Epub 2013 Sep 6","volume":"27","author":"D L\u00f3pez-Terrada","year":"2014","unstructured":"L\u00f3pez-Terrada, D. et al. Children\u2019s Oncology Group Liver Tumor Committee. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol 27, 472\u2013491, doi: 10.1038\/modpathol.2013.80. Epub 2013 Sep 6 (2014).","journal-title":"Mod Pathol"},{"key":"BFsrep38347_CR4","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1200\/JCO.2000.18.22.3819","volume":"15","author":"J Pritchard","year":"2000","unstructured":"Pritchard, J. et al. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach\u2013results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol 15, 3819\u20133828 (2000).","journal-title":"J Clin Oncol"},{"key":"BFsrep38347_CR5","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/cncr.10282","volume":"94","author":"JM Schnater","year":"2002","unstructured":"Schnater, J. M. et al. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer 94, 1111\u20131120 (2002).","journal-title":"Cancer"},{"key":"BFsrep38347_CR6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/00000658-199102000-00004","volume":"213","author":"B Koneru","year":"1991","unstructured":"Koneru, B. et al. Liver transplantation for hepatoblastoma. The American experience. Ann Surg 213, 118\u2013121 (1991).","journal-title":"Ann Surg"},{"key":"BFsrep38347_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/01.mph.0000141348.62532.73","volume":"26","author":"P Bertolini","year":"2004","unstructured":"Bertolini, P. et al. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss. J Pediatr Hematol Oncol 26, 649\u2013655 (2004).","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFsrep38347_CR8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH804>3.0.CO;2-R","volume":"193","author":"WS Park","year":"2001","unstructured":"Park, W. S. et al. Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma. J Pathol 193, 483\u2013490 (2001).","journal-title":"J Pathol"},{"key":"BFsrep38347_CR9","first-page":"551","volume":"15","author":"H Yamaoka","year":"2006","unstructured":"Yamaoka, H. et al. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors. Oncol Rep 15, 551\u2013556 (2006).","journal-title":"Oncol Rep"},{"key":"BFsrep38347_CR10","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.ejca.2011.10.019","volume":"48","author":"R Purcell","year":"2012","unstructured":"Purcell, R. et al. Potential biomarkers for hepatoblastoma: results from the SIOPEL-3 study. Eur J Cancer 48, 1853\u20131859 (2012).","journal-title":"Eur J Cancer"},{"key":"BFsrep38347_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/mpo.1280","volume":"38","author":"D Von Schweinitz","year":"2002","unstructured":"Von Schweinitz, D. et al. Prognostic impact of molecular genetic alterations in hepatoblastoma. Med Pediatr Oncol 38, 104\u2013108 (2002).","journal-title":"Med Pediatr Oncol"},{"key":"BFsrep38347_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.semcancer.2010.12.010","volume":"21","author":"KN Nejak-Bowen","year":"2011","unstructured":"Nejak-Bowen, K. N. & Monga, S. P. Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin Cancer Biol 21, 44\u201358 (2011).","journal-title":"Semin Cancer Biol"},{"key":"BFsrep38347_CR13","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1053\/j.gastro.2014.05.004","volume":"147","author":"J Tao","year":"2014","unstructured":"Tao, J. et al. Activation of beta-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice. Gastroenterology 147, 690\u2013701 (2014).","journal-title":"Gastroenterology"},{"key":"BFsrep38347_CR14","first-page":"551","volume":"15","author":"H Yamaoka","year":"2006","unstructured":"Yamaoka, H., Ohtsu, K., Sueda, T., Yokoyama, T. & Hiyama, E. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors. Oncol Rep 15, 551\u2013556 (2006).","journal-title":"Oncol Rep"},{"key":"BFsrep38347_CR15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","volume":"14","author":"S Cairo","year":"2008","unstructured":"Cairo, S. et al. Hepatic stem-like phenotype and interplay of Wnt\/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell 14, 471\u2013484 (2008).","journal-title":"Cancer Cell"},{"key":"BFsrep38347_CR16","doi-asserted-by":"crossref","unstructured":"Purcell, R. et al. HGF\/c-Met related activation of \u03b2-catenin in hepatoblastoma. J Exp Clin Cancer Res 30, doi: 10.1186\/1756\u20139966\u201330\u201396 (2011).","DOI":"10.1186\/1756-9966-30-96"},{"key":"BFsrep38347_CR17","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.humpath.2008.07.022","volume":"40","author":"D Lopez-Terrada.","year":"2009","unstructured":"Lopez-Terrada. D. et al. Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors. Hum Pathol 40, 783\u2013794 (2009).","journal-title":"Hum Pathol"},{"key":"BFsrep38347_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1478-3231.2011.02646.x","volume":"32","author":"H Li","year":"2012","unstructured":"Li, H. et al. Deregulation of Hippo kinase signalling in human hepatic malignancies. Liver Int 32, 38\u201347 (2012).","journal-title":"Liver Int"},{"key":"BFsrep38347_CR19","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/j.jpedsurg.2011.09.003","volume":"46","author":"Y Ueda","year":"2011","unstructured":"Ueda, Y. et al. Wnt signaling and telomerase activation of hepatoblastoma: correlation with chemosensitivity and surgical resectability. J Pediatr Surg 46, 2221\u20132227 (2011).","journal-title":"J Pediatr Surg"},{"key":"BFsrep38347_CR20","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/ijc.23613","volume":"123","author":"S Honda","year":"2008","unstructured":"Honda, S. et al. The methylation status of RASSF1A promoter predicts responsiveness to chemotherapy and eventual cure in hepatoblastoma patients. Int J Cancer 123, 1117\u20131125 (2008).","journal-title":"Int J Cancer"},{"key":"BFsrep38347_CR21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0002-9440(10)64567-1","volume":"157","author":"RG Weber","year":"2000","unstructured":"Weber, R. G., Pietsch, T., von Schweinitz, D. & Lichter, P. Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome. Am J Pathol 157, 571\u2013578 (2000).","journal-title":"Am J Pathol"},{"key":"BFsrep38347_CR22","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1002\/hep.27243","volume":"60","author":"D Jia","year":"2014","unstructured":"Jia, D. et al. Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex. Hepatology 60, 1686\u20131696 (2014).","journal-title":"Hepatology"},{"key":"BFsrep38347_CR23","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.jhep.2014.08.009","volume":"61","author":"M Eichenm\u00fcller","year":"2014","unstructured":"Eichenm\u00fcller, M. et al. The genomic landscape of hepatoblastoma and their progenies with HCC-like features. J Hepatol 61, 1312\u20131320 (2014).","journal-title":"J Hepatol"},{"key":"BFsrep38347_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S0022-3476(98)70084-8","volume":"133","author":"J Feusner","year":"1998","unstructured":"Feusner, J., Buckley, J., Robison, L., Ross, J. & Van Tornout, J. Prematurity and hepatoblastoma: more than just an association? J Pediatr 133, 585\u2013586 (1998).","journal-title":"J Pediatr"},{"key":"BFsrep38347_CR25","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nature15540","volume":"528","author":"DA Oldridge","year":"2015","unstructured":"Oldridge, D. A. et al. Genetic predisposition to neuroblastoma mediated by a LMO1 super- enhancer polymorphism. Nature 528, 418\u2013421 (2015).","journal-title":"Nature"},{"key":"BFsrep38347_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/cncr.29706","volume":"122","author":"KR Bosse","year":"2016","unstructured":"Bosse, K. R. & Maris, J. M. Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations. Cancer 122, 20\u201333 (2016).","journal-title":"Cancer"},{"key":"BFsrep38347_CR27","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1002\/ajmg.a.36638","volume":"164A","author":"R Venkatramani","year":"2014","unstructured":"Venkatramani, R. et al. Congenital abnormalities and hepatoblastoma: a report from the Children\u2019s Oncology Group (COG) and the Utah Population Database (UPDB). Am J Med Genet A 164A, 2250\u20132255 (2014).","journal-title":"Am J Med Genet A"},{"key":"BFsrep38347_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.1469-0705.2000.00171.x","volume":"16","author":"JC Shih","year":"2000","unstructured":"Shih, J. C. et al. Congenital hepatoblastoma. Ultrasound Obstet Gynecol 16, 103 (2000).","journal-title":"Ultrasound Obstet Gynecol"},{"key":"BFsrep38347_CR29","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/ajmg.1320430621","volume":"43","author":"LJ Hughes","year":"1992","unstructured":"Hughes, L. J. & Michels, V. V. Risk of hepatoblastoma in familial adenomatous polyposis. Am J Med Genet 43, 1023\u20131025 (1992).","journal-title":"Am J Med Genet"},{"key":"BFsrep38347_CR30","doi-asserted-by":"publisher","first-page":"e0130444","DOI":"10.1371\/journal.pone.0130444","volume":"10","author":"GY Hung","year":"2015","unstructured":"Hung, G. Y., Horng, J. L., Yen, H. J. & Lee, C. Y. Infant Cancer in Taiwan: Incidence and Trends (1995\u20132009). PLoS One 10, e0130444. eCollection (2015).","journal-title":"PLoS One"},{"key":"BFsrep38347_CR31","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/MPH.0000000000000129","volume":"36","author":"AD Trobaugh-Lotrario","year":"2014","unstructured":"Trobaugh-Lotrario, A. D., Venkatramani, R. & Feusner, J. H. Hepatoblastoma in children with Beckwith-Wiedemann syndrome: Does it warrant different treatment? J Pediatr Hematol Oncol 36, 369\u2013373 (2014).","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFsrep38347_CR32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrc1609","volume":"5","author":"NE Hynes","year":"2005","unstructured":"Hynes, N. E. & Lane, H. A. ERBB receptors and cancer: The complexity of targeted inhibitors. Nat Rev Cancer 5, 341\u2013354 (2005).","journal-title":"Nat Rev Cancer"},{"key":"BFsrep38347_CR33","doi-asserted-by":"publisher","first-page":"5268","DOI":"10.1158\/1078-0432.CCR-05-1554","volume":"12","author":"M Scaltriti","year":"2006","unstructured":"Scaltriti, M. & Baselga, J. The Epidermal Growth Factor Receptor Pathway: A Model for Targeted Therapy. Clin Cancer Res 12, 5268\u20135272 (2006).","journal-title":"Clin Cancer Res"},{"key":"BFsrep38347_CR34","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1101\/gad.1596707","volume":"21","author":"FB Furnari","year":"2007","unstructured":"Furnari, F. B. et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21, 2683\u20132710 (2007).","journal-title":"Genes Dev"},{"key":"BFsrep38347_CR35","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/j.1600-0854.2009.00917.x","volume":"10","author":"H Sabe","year":"2009","unstructured":"Sabe, H. et al. The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis. Traffic 10, 982\u2013993 (2009).","journal-title":"Traffic"},{"key":"BFsrep38347_CR36","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","volume":"26","author":"PJ Roberts","year":"2007","unstructured":"Roberts, P. J. & Der, C. J. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26, 3291\u20133310 (2007).","journal-title":"Oncogene"},{"key":"BFsrep38347_CR37","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1158\/0008-5472.CAN-07-5237","volume":"68","author":"D Lin","year":"2008","unstructured":"Lin, D. et al. ASAP1, a gene at 8q24, is associated with prostate cancer metastasis. Cancer Res 68, 4352\u20134359 (2008).","journal-title":"Cancer Res"},{"key":"BFsrep38347_CR38","first-page":"280","volume":"7","author":"T Hou","year":"2013","unstructured":"Hou, T. et al. Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer. Int J Clin Exp Pathol 7, 280\u2013287 (2013).","journal-title":"Int J Clin Exp Pathol"},{"key":"BFsrep38347_CR39","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1158\/1078-0432.CCR-04-1941","volume":"11","author":"JP Ehlers","year":"2005","unstructured":"Ehlers, J. P., Worley, L., Onken, M. D. & Harbour, J. W. ASAP1 is located in an amplified region of chromosome 8q and is overexpressed in uveal melanoma. Clin Cancer Res 11, 3609\u20133613 (2005).","journal-title":"Clin Cancer Res"},{"key":"BFsrep38347_CR40","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1023\/A:1015720220602","volume":"57","author":"S Utsuki","year":"2002","unstructured":"Utsuki, S. et al. Relationship between the expression of E-, N-cadherins and \u03b2-catenin and tumor grade in astrocytomas. J Neurooncol 57, 187\u2013192 (2002).","journal-title":"J Neurooncol"},{"key":"BFsrep38347_CR41","doi-asserted-by":"publisher","first-page":"e67811","DOI":"10.1371\/journal.pone.0067811","volume":"8","author":"R Lamb","year":"2013","unstructured":"Lamb, R. et al. Wnt pathway activity in breast cancer sub-types and stem-like cells. PLoS One 8, e67811 (2013).","journal-title":"PLoS One"},{"key":"BFsrep38347_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11010-013-1700-0","volume":"381","author":"LJ Wang","year":"2013","unstructured":"Wang, L. J., Bai, L., Su, D., Zhang, T. & Mao, Z. Y. Proinflammatory conditions promote hepatocellular carcinoma onset and progression via activation of Wnt and EGFR signaling pathways. Mol Cell Biochem 381, 173\u2013181 (2013).","journal-title":"Mol Cell Biochem"},{"key":"BFsrep38347_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00535-013-0907-x","volume":"49","author":"C Berasain","year":"2014","unstructured":"Berasain, C. & Avila, M. A. The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis. J Gastroenterol 49, 9\u201323 (2014).","journal-title":"J Gastroenterol"},{"key":"BFsrep38347_CR44","doi-asserted-by":"publisher","first-page":"e74618","DOI":"10.1371\/journal.pone.0074618","volume":"8","author":"MH Fl\u00e5geng","year":"2013","unstructured":"Fl\u00e5geng, M. H., Knappskog, S., Haynes, B. P., L\u00f8nning, P. E. & Mellgren, G. Inverse regulation of EGFR\/HER1 and HER2\u20134 in normal and malignant human breast tissue. PLoS One 8, e74618 (2013).","journal-title":"PLoS One"},{"key":"BFsrep38347_CR45","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1242\/jcs.116277","volume":"126","author":"K Ishibashi","year":"2013","unstructured":"Ishibashi, K. et al. Nuclear ErbB4 signaling through H3K9me3 is antagonized by EGFR- activated c-Src. J Cell Sci 126, 625\u2013637 (2013).","journal-title":"J Cell Sci"},{"key":"BFsrep38347_CR46","first-page":"891","volume":"54","author":"Y Bai","year":"2014","unstructured":"Bai, Y. et al. The RNA expression signature of the HepG2 cell line as determined by the integrated analysis of miRNA and mRNA expression profiles. Gene 54, 891\u2013100 (2014).","journal-title":"Gene"},{"key":"BFsrep38347_CR47","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1872-034X.2007.00304.x","volume":"38","author":"H Itabashi","year":"2008","unstructured":"Itabashi, H. et al. Angiotensin II and epidermal growth factor receptor cross-talk mediated by a disintegrin and metalloprotease accelerates tumor cell proliferation of hepatocellular carcinoma cell lines. Hepatol Res 38, 601\u2013613 (2008).","journal-title":"Hepatol Res"},{"key":"BFsrep38347_CR48","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.gene.2012.12.106","volume":"518","author":"S Costantini","year":"2013","unstructured":"Costantini, S., Di Bernardo, G., Cammarota, M., Castello, G. & Colonna, G. Gene expression signature of human HepG2 cell line. Gene 518, 335\u2013345 (2013).","journal-title":"Gene"},{"key":"BFsrep38347_CR49","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.humpath.2008.07.022","volume":"40","author":"D L\u00f3pez-Terrada","year":"2009","unstructured":"L\u00f3pez-Terrada, D. et al. Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors. Hum Pathol 40, 783\u2013794 (2009).","journal-title":"Hum Pathol"},{"key":"BFsrep38347_CR50","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/1476-4598-9-236","volume":"9","author":"T Hu","year":"2010","unstructured":"Hu, T. & Li, C. Convergence between Wnt-\u03b2-catenin and EGFR signaling in cancer. Mol Cancer 9, 236 (2010).","journal-title":"Mol Cancer"},{"key":"BFsrep38347_CR51","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1242\/dev.124.16.3209","volume":"124","author":"D Szuts","year":"1997","unstructured":"Szuts, D., Freeman, M. & Bienz, M. Antagonism between EGFR and Wingless signalling in the larval cuticle of Drosophila. Development 124, 3209\u20133219 (1997).","journal-title":"Development"},{"key":"BFsrep38347_CR52","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/embo-reports\/kve019","volume":"2","author":"M Freeman","year":"2001","unstructured":"Freeman, M. & Bienz, M. EGF receptor\/Rolled MAP kinase signalling protects cells against activated Armadillo in the Drosophila eye. EMBO Rep 2, 157\u2013162 (2001).","journal-title":"EMBO Rep"},{"key":"BFsrep38347_CR53","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1053\/j.gastro.2008.05.080","volume":"135","author":"R Sindhi","year":"2008","unstructured":"Sindhi, R. et al. Genetic variants in major histocompatibility complex-linked genes associate with pediatric liver transplant rejection. Gastroenterology 135, 830\u2013839 (2008).","journal-title":"Gastroenterology"},{"key":"BFsrep38347_CR54","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nat Methods 12, 357\u2013360 (2015).","journal-title":"Nat Methods"},{"key":"BFsrep38347_CR55","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059\u2013014\u20130550\u20138","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology 15, 550, doi: org\/10.1186\/s13059\u2013014\u20130550\u20138 (2014).","journal-title":"Genome Biology"},{"key":"BFsrep38347_CR56","unstructured":"Bass, J. D., Dabney, A. & Robinson, D. qvalue: Q-value estimation for false discovery rate control. R package version 2.3.0. (2015) (Accessed: 01\/08\/2016). Available at: http:\/\/qvalue.princeton.edu\/, http:\/\/github.com\/jdstorey\/qvalue."},{"key":"BFsrep38347_CR57","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0003-2697(02)00311-1","volume":"309","author":"C Tricarico","year":"2002","unstructured":"Tricarico, C. et al. Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Anal Biochem 309, 293\u2013300 (2002).","journal-title":"Anal Biochem"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep38347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep38347","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep38347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T20:10:18Z","timestamp":1672863018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep38347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,2]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep38347"],"URL":"https:\/\/doi.org\/10.1038\/srep38347","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,2]]},"assertion":[{"value":"15 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38347"}}